Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Ordaos

Request full access

Creates bespoke mini-proteins to help drug hunters deliver life-saving treatments

New York City, United StatesFounded 2019Biotech & Life Sciences

About Ordaos

Ordaos Bio is a pioneering startup that leverages generative AI to revolutionize the drug discovery process. Traditional methods of drug discovery are often slow, costly, and have a high failure rate. Ordaos Bio aims to address these challenges by using advanced artificial intelligence to accelerate the development of life-saving medicines. Generative AI, unlike predictive AI, can create new data and solutions, making it particularly effective in identifying potential drug candidates that might be overlooked by conventional methods.

The company primarily serves biopharmaceutical companies that are looking to streamline their drug development pipelines. By partnering with these firms, Ordaos Bio helps reduce the time and cost associated with bringing new drugs to market. This is crucial in the fight against diseases where current capabilities fall short due to financial and temporal constraints.

Operating in the healthcare and biotechnology market, Ordaos Bio's business model revolves around offering AI-driven drug discovery services. They generate revenue through partnerships and collaborations with biopharmaceutical companies, who pay for access to Ordaos Bio's cutting-edge technology and expertise. This model not only provides a steady income stream but also positions Ordaos Bio as a key player in the future of medical research.

The team at Ordaos Bio is composed of visionaries in AI, digital drug discovery, academic research, and drug development. They are committed to creating a paradigm shift in the industry, making the hidden aspects of drug discovery visible and actionable through their innovative use of generative AI.

In summary, Ordaos Bio is transforming the landscape of drug discovery by making it faster, cheaper, and more efficient through the use of generative AI. Their focus on collaboration with biopharmaceutical companies ensures that they are at the forefront of bringing new, life-saving drugs to market.

Source: Dealroom company data

At a glance

Founded
2019
Headquarters
New York City, United States
Sector
Biotech & Life Sciences

Ordaos in the New York City ecosystem

Live from Dealroom

The Ordaos office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

5 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Seed5 investors entered at this stage

  • VTC Ventures
  • Citta Ventures
  • Route 66 Ventures
  • Banyan Pacific
  • IAG Capital Partners
Team profiled 9 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 3 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
4 countries with
team presence
🇺🇸 United States86.4%
🇵🇹 Portugal4.5%
🇷🇴 Romania4.5%
🇩🇿 Algeria4.5%
4 countries shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Ordaos on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Ordaos on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.